drugset / Trial / NCT07699471
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the efficacy and safety of canvuparatide administered as a once-weekly (QW) treatment to adult study participants with hypoparathyroidism (HypoPT).
Timeline
- Start
- 2026-08
- Primary completion
- 2028-01
- Completion
- 2029-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Canvuparatide | Protein / enzyme biologic | 400 ug/ml | Subcutaneous |
| Comparator | Canvuparatide | Protein / enzyme biologic | 600 ug/ml | Subcutaneous |
| Comparator | Canvuparatide | Protein / enzyme biologic | 800 ug/ml | Subcutaneous |
| Comparator | Canvuparatide | Protein / enzyme biologic | 1000 ug/ml | Subcutaneous |
| Comparator | Canvuparatide | Protein / enzyme biologic | 1200 ug/ml | Subcutaneous |
| Comparator | Canvuparatide | Protein / enzyme biologic | 1400 ug/ml | Subcutaneous |
| Comparator | Canvuparatide | Protein / enzyme biologic | 1600 ug/ml | Subcutaneous |